| scholarly article | Q13442814 |
| P50 | author | Isaiah J. Fidler | Q56221878 |
| Toshio Kuwai | Q60891714 | ||
| Yasuhiko Kitadai | Q98387416 | ||
| P2093 | author name string | Stanley R Hamilton | |
| Toru Nakamura | |||
| Corazon D Bucana | |||
| Takamitsu Sasaki | |||
| P2860 | cites work | Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity | Q35103262 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metastatic potential | Q122615215 |
| P304 | page(s) | 2567-2574 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential | |
| P478 | volume | 119 |
| Q37826352 | A digest on the role of the tumor microenvironment in gastrointestinal cancers |
| Q29308099 | Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? |
| Q37724639 | Angiogenesis and lymphangiogenesis of gastric cancer |
| Q54384034 | Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model. |
| Q40109529 | Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation |
| Q39117804 | Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells. |
| Q26774159 | Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth |
| Q34268727 | Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer |
| Q37845669 | Cell surface markers in colorectal cancer prognosis |
| Q42373333 | Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma. |
| Q35993392 | Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines. |
| Q46238888 | Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species |
| Q37154472 | Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer |
| Q33968953 | E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion |
| Q91618178 | Evaluation of colorectal cancer subtypes and cell lines using deep learning |
| Q41983615 | Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer |
| Q33951007 | Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer |
| Q55340110 | Expression of cancer-associated fibroblast markers in advanced colorectal cancer. |
| Q37662632 | High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis |
| Q36289382 | Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up. |
| Q33852653 | Impact of PINCH expression on survival in colorectal cancer patients |
| Q35725355 | Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy |
| Q43118428 | Intrathecal delivery of PDGF produces tactile allodynia through its receptors in spinal microglia |
| Q36559630 | Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors. |
| Q47756210 | Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
| Q42655265 | KIT, PDGFRalpha and EGFR analysis in nephroblastoma |
| Q34309316 | Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling |
| Q33595542 | Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact |
| Q90115642 | Metastatic components in colorectal cancer |
| Q33802125 | MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression |
| Q36500108 | Molecular targeting of liposomal nanoparticles to tumor microenvironment |
| Q90356200 | Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance |
| Q30479724 | Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content |
| Q34140712 | PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells |
| Q37706090 | PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway |
| Q30536377 | PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells |
| Q57801663 | PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors |
| Q38528174 | Pericytes in sarcomas of bone |
| Q84118992 | Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer |
| Q37463413 | Revisiting the seed and soil in cancer metastasis |
| Q58113158 | Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis |
| Q39310184 | Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer |
| Q34029444 | Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo |
| Q37736897 | TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells. |
| Q38268000 | Targeting platelet-derived growth factor (PDGF) signaling in gastrointestinal cancers: preclinical and clinical considerations |
| Q40005161 | Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy. |
| Q34393461 | Targeting the PDGF signaling pathway in tumor treatment |
| Q35569799 | Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. |
| Q39120772 | The Role of PDGFs and PDGFRs in Colorectal Cancer. |
| Q34343645 | The tumor microenvironment in colorectal carcinogenesis |
| Q37174369 | Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness |
Search more.